The Latest Breaking News on Pharma

No one really expected the pharmaceutical industry to lie down and take it when Congress authorized Medicare to start negotiating prices of the prescription drugs it buys for enrollees.

‘It’s kind of sad in some ways that we keep coming and saying we’re getting bigger and bigger seizures’

French President Emmanuel Macron has vowed to relocate the production of 50 key pharmaceutical drugs, 25 of them - in the coming weeks - to tackle an ongoing shortage of medicines in France.

Pharma giant Merck unveiled new data for a potential competitor to weight loss drugs from Novo Nordisk and Eli Lilly.

Despite a slowdown of Covid-19 vaccine sales in the last reported quarter, biopharmaceutical giant Pfizer (PFE) is positioned to deliver robust growth this year and beyond, thanks to the strength of its in-line products and expected near-term launches and revenue distribution from the recent acquisition. So, let’s find out if…

As the biotech industry looks well-positioned for solid growth driven by strong government support and a growing foothold of personalized medicines, it could be wise for investors to buy fundamentally strong biotech stocks Gilead Sciences (GILD) and Regeneron Pharmaceuticals (REGN). However, fundamentally weak Titan Pharmaceuticals (TTNP) might be best avoided.…

The County Durham company said it was focussed on growth after a successful year

Catalyst Pharmaceuticals (CPRX) witnessed significant bottom-line growth in the first quarter but missed expectations. Does the biopharmaceutical company deserve a place in your portfolio in the near future? Let’s look at its financial metrics to get an idea….

As part of a weekly showcase of future leaders and inspirational young New Zealanders from the Hyundai Pinnacle Programme, Isla Day wants to develop better connections between industry and academia in the field of drug development – and fight for climate justice | Content Partnership